Abused Drugs Modulate RGS4 mRNA Levels in Rat Brain: Comparison Between Acute Drug Treatment and a Drug Challenge after Chronic Treatment
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
While different classes of abused drugs interact with distinct signaling substrates, it appears that all utilize receptors in the mesolimbic dopamine system to mediate their reinforcing effects. The regulator of G-protein signaling (RGS) proteins modulate G-protein coupled receptor (GPCR) signaling by increasing the rate of GTP hydrolysis of G proteins. This study was undertaken to determine whether morphine, cocaine, or amphetamine would modulate RGS4 mRNA levels in relevant brain regions. Acute administration of morphine and cocaine decreased levels of RGS4 mRNA in the reticulotegmental pontine nucleus (RtTg) and locus coeruleus (LC). Increases in RGS 4 mRNA levels were observed in the nucleus accumbens (NAc) and dorsal central gray (CGD). Acute drug challenge after chronic drug administration increased RGS4 mRNA in the CGD and decreased RGS4 levels in the red nucleus and RtTg. Interestingly, the LC exhibited biphasic modulation, with decreased RGS4 mRNA levels after acute administration and increased levels after chronic administration. These findings indicate that RGS4 mRNA levels are modulated in a similar manner by different drugs of abuse and imply that a common substrate could mediate some effects of abused drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070 · cited 1×
“Both D1 and D2 receptors in the mesolimbic dopamine system have been shown to play an important role in mediating drug reinforcement (Koob, 1992).”
BackgroundRobinson, T. E., & Becker, J. B. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90002-0 · Cited by 1,796
Paulson, P. E., Camp, D. M., & Robinson, T. E. (1991) · Psychopharmacology · doi:10.1007/bf02244248 · Cited by 455
Cited by
Kelley, A. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.016 · Cited by 778
PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation
Peltier, J., O'Neill, A., & Schaffer, D. V. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20506 · Cited by 443
Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3‐kinase activation
Bijur, G. N., & Jope, R. S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02113.x · Cited by 331
Horwood, J. M., Dufour, F., Laroche, S., & Davis, S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04859.x · Cited by 293
Lang, K., Drell, T. L., Lindecke, A., Niggemann, B., Kaltschmidt, C., Zaenker, K. S., & Entschladen, F. (2004) · International Journal of Cancer · doi:10.1002/ijc.20410 · Cited by 256
Metadata
- Authors
- Bishop, G. B., Cullinan, W. E., Curran, E., & Gutstein, H. B.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 10
- Issue
- 3
- Pages
- 334-343
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2036997225
- Cited by
- 88
- References
- 4
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.